Inhaled corticosteroid advertising
Executive Summary
GlaxoSmithKline is considering running "reminder" ads for the inhaled corticosteroid products Flovent (fluticasone) and Advair (fluticasone/salmeterol) in light of FDA removal of black box from class warning on adrenal insufficiency (1"The Pink Sheet" Feb. 4, p. 25). The warning remains in labeling and will remain in the fair balance section of product-and-use ads...